“LEQEMBI®” (Lecanemab) Approved for the Treatment of Alzheimer’s Disease in Hong Kong
In Jul. 10, 2024, Eisai and Biogen announced that the Department of Health in Hong Kong has approved…
WHO prequalifies the first self-test for hepatitis C virus
On Jul. 10, 2024, The World Health Organization (WHO) announced it had has prequalified the first hepatitis C…
Researchers pinpoint brain cells that delay first bite of food
On Jul. 10, 2024, Scripps Research scientists announced they have identified a group of neurons in a small…
Twist Bioscience Launched Synthetic RNA Control for H5N1 Influenza A
On Jul. 9, 2024, Twist Bioscience announced the expansion of its growing portfolio of synthetic viral controls with…
Late-pregnancy RSV vaccination not associated with poor birth outcomes
On Jul. 8, 2024, a study reported that babies exposed to maternal RSV (respiratory syncytial virus) vaccination in…
CDC Reported Fourth Human Case of H5 Bird Flu Tied to Dairy Cow Outbreak
On Jul. 3, 2024, the Centers for Disease Control and Prevention (CDC) reported that a human case of…
Dupixent® (dupilumab) Approved in the European Union as the First-ever Targeted Therapy for Patients with COPD
On Jul. 3, 2024, Regeneron Pharmaceuticals and Sanofi announced that the European Commission (EC) has approved Dupixent® (dupilumab)…
NIH researchers discovered a new face-detecting brain circuit
On Jul. 2, 2024, scientists at the National Institutes of Health (NIH) have uncovered a brain circuit in…
Study detected bacteria in 35% of commercial tattoos and permanent makeup inks sold in U.S.
On Jul. 2, 2024, a study was released that showed evidence that commercial tattoo and PMU inks are…
Emergent BioSolutions Awarded $250+ Million in Contract to Supply U.S. Government with Four Critical Medical Countermeasure Products
On Jul. 2, 2024, Emergent BioSolutions announced it had received more than $250 millionin contract modifications from the…
Moderna Received $176 million Award through BARDA to Accelerate Development of mRNA-based Pandemic Influenza Vaccine
On Jul. 2, 2024, Moderna announced a project award of $176 million through the Rapid Response Partnership Vehicle…
USDA, University Researchers Develop Near Chromosome-Level Genome for the Mojave Poppy Bee
On Jul. 1, 2024, scientists at the U.S. Department of Agriculture (USDA)’s Agricultural Research Service (ARS) and university research partners…
CIRM awarded $26 million to advance clinical research across cancer, heart conditions, and rare diseases
On Jun. 28, 2024, the California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated…
FDA Permited Marketing of First Point-of-Care Hepatitis C RNA Test
On Jun. 27, 2024, the U.S. Food and Drug Administration granted marketing authorization to Cepheid for the Xpert…
Biotechnology | CDC | COVID-19 | Influenza | Vaccine
CDC Recommended Updated 2024-2025 COVID-19 and Flu Vaccines for Fall/Winter Virus Season
On Jun. 27, 2024, the U.S. Centers for Disease Control and Prevention’s (CDC) recommended the updated 2024-2025 COVID-19…
C2N’s Precivity™ Tests are Now Offered Through Mayo Clinic Laboratories
On Jun. 27, 2024, C2N Diagnostics (C2N), has entered into a non-exclusive agreement with Mayo Clinic Laboratories, for…
NIAID Discovery Leads to Novel Probiotic for Eczema
On Jun. 26, 2024, National Institute of Allergy and Infectious Diseases (NIAID) announced that research has led to…
Biotechnology | Diagnostics | Disease | Oncology | Therapeutics | WHO
Nearly 1.8 billion adults at risk of disease from not doing enough physical activity
On Jun. 26. 2024, the World Health Organization reported that new data show that nearly one third (31%)…
Biotechnology | CDC | Therapeutics | Vaccine
CDC Updated RSV Vaccination Recommendation for Adults
On Jun. 26, 2024, the U.S. Centers for Disease Control and Prevention (CDC) updated its recommendation for the…
Biotechnology | Influenza | Therapeutics | USDA | Vaccine | Veterinary
USDA Approved Merck Animal Health’s NOBIVAC® NXT Canine Flu H3N2 – The First and Only RNA-Particle Technology Vaccine for Canine Influenza
On Jun. 25, 2024, Merck Animal Health announced U.S. Department of Agriculture (USDA) approval of NOBIVAC® NXT Canine…
Just – Evotec Biologics selected by U.S. Department of Defense for Manufacturing Optimization Program
On Jun. 25, 2024, Evotec announced that its Seattle-based subsidiary, Just – Evotec Biologics, was selected by the…
Finland started bird flu vaccinations for humans, in world first
On Jun. 25, 2024, the Finnish Institute for Health and Welfare (THL) announced that they planned to offer…
Study implicates Neanderthal DNA in autism susceptibility
On Jun. 24, 2024, collaborative research involving two Clemson University scientists has found that some genetic traits modern…
Novo Nordisk announced 4.1 billion USD investment to expand US manufacturing capacity
On Jun. 24, 2024, Novo Nordisk announced plans to invest 4.1 billion US dollars to build a second…
Biotechnology | Disease | FDA | Medicine | Therapeutics
FDA Expanded Approval of Gene Therapy for Patients with Duchenne Muscular Dystrophy
On Jun. 20, 2024, the U.S. Food and Drug Administration expanded the approval of Sarepta Therapeutics’ Elevidys (delandistrogene…
Agriculture | Biotechnology | Chemistry | Diagnostics | Environmental | EPA | Therapeutics
Air pollution accounted for 8.1 million deaths globally in 2021, Becoming the second leading risk factor for death
On Jun. 19, 2024, the Institute for Health Metrics and Evaluation (IHME) released a comprehensive new report that…
Houston Zoo Elephant Received First Ever mRNA EEHV Vaccine
On Jun. 18, 2024, the Houston Zoo announced that Tess, a 40-year-old Asian elephant at the Zoo, had…
U.S. FDA Approved CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Prevention of Invasive Pneumococcal Disease and Pneumococcal Pneumonia in Adults
On Jun. 17, 2024, Merck announced that the U.S. Food and Drug Administration (FDA) had approved CAPVAXIVE™ (Pneumococcal…
Infectious H5N1 Influenza Virus in Raw Milk Rapidly Declines with Heat Treatment
On Jun. 14, 2024, the National Institute of Allergy and Infectious Diseases (NIAID, reported that the amount of…
Genome of the last living wild horse species mapped
On Jun. 13. 2024, University of Minnesota researchers announced they have successfully mapped the complete genome of the…